Globe Life (GL) is a life & health insurance company in the Financials sector. Listed on the NASDAQ, Globe Life is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $162.52.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $162.52 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 17.86% |
| Risk / Std Dev (Annualized) | 35.82% |
| Sharpe Ratio (rf=4.5%) | 0.37 |
S&P 500 Context
- Sector: Financials
- Sub-Industry: Life & Health Insurance
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 17.86% with an annualized volatility of 35.82%. The Sharpe ratio of 0.37 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 12.62B |
| Enterprise Value | 15.44B |
| Trailing P/E | 11.25 |
| Forward P/E | 9.76 |
| Price to Book | 2.08 |
| Price to Sales | 2.08 |
| EV/Revenue | 2.54 |
| EV/EBITDA | 9.43 |
| Profitability | | | Profit Margin | 19.38% | | Operating Margin | 23.75% | | ROE | 20.46% | | ROA | 3.31% |
| Growth | | | Revenue Growth | 5.4% | | Earnings Growth | 12.6% |
| Dividend | | | Dividend Yield | 81.0% | | Payout Ratio | 7.89% | | 5Y Avg Yield | 80.0% |
| Financial Health | | | Total Revenue | 6.07B | | Total Debt | 3.26B | | Total Cash | 0.44B | | Free Cash Flow | 1.32B | | Operating Cash Flow | 1.39B |
| Price & Technical | | | 52W High | $163.5$ | | 52W Low | $116.73$ | | 50-Day Avg | $151.41$ | | 200-Day Avg | $142.04$ | | Beta | 0.5 | | Shares Outstanding | 0.08B | | Float Shares | 0.08B | | Insider Holdings | 0.69% | | Institutional Holdings | 86.47% | | Short Ratio | 0.01 | | Short % of Float | 0.01% |
| Analyst Targets | | | Target High | $208.0$ | | Target Low | $147.0$ | | Target Mean | $175.91$ | | Target Median | $180.0$ | | # of Analysts | 11 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.